EP Patent

EP1326668A2 — Inhaler

Assigned to Glaxo Group Ltd · Expires 2003-07-16 · 23y expired

What this patent protects

The invention provides an inhaler for delivery of a dry powder medicament, the inhaler comprising a breath sensor (690) for sensing the breath of a patient; means for transporting (622) the medicament to a delivery position; and electro-mechanical coupling means (628) for actuati…

USPTO Abstract

The invention provides an inhaler for delivery of a dry powder medicament, the inhaler comprising a breath sensor (690) for sensing the breath of a patient; means for transporting (622) the medicament to a delivery position; and electro-mechanical coupling means (628) for actuating said transport means (622), wherein said coupling means (628) is directly or indirectly responsive to the breath sensor (690).

Drugs covered by this patent

Patent Metadata

Patent number
EP1326668A2
Jurisdiction
EP
Classification
—
Expires
2003-07-16
Drug substance claim
No
Drug product claim
No
Assignee
Glaxo Group Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.